Surgery Partners Inc

$ 15.95

2.70%

10 Aug - close price

  • Market Cap 2,031,140,000 USD
  • Current Price $ 15.95
  • High / Low $ 16.46 / 14.81
  • Stock P/E N/A
  • Book Value 13.03
  • EPS -0.59
  • Next Earning Report 2026-08-10
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA 0.04 %
  • ROE 0.03 %
  • 52 Week High 24.10
  • 52 Week Low 11.41

About

Surgery Partners, Inc. owns and operates a network of surgical facilities and ancillary services in the United States. The company is headquartered in Brentwood, Tennessee.

Analyst Target Price

$18.64

Quarterly Earnings

Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
Reported Date 2026-08-102026-05-052026-03-022025-11-102025-08-052025-05-122025-03-032024-11-122024-08-062024-05-072024-02-262023-11-07
Reported EPS None-0.030.120.130.170.040.440.190.210.10.440.19
Estimated EPS -0.03-0.140.30380.160.140.050.37690.260.20.080.380.15
Surprise 00.11-0.1838-0.030.03-0.010.0631-0.070.010.020.060.04
Surprise Percentage None%78.5714%-60.5003%-18.75%21.4286%-20%16.7418%-26.9231%5%25%15.7895%26.6667%

Next Quarterly Earnings

Jun 2026
Reported Date 2026-08-10
Fiscal Date Ending 2026-06-30
Estimated EPS -0.03
Currency USD

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: SGRY

...
Surgery Partners (SGRY) Q2 Earnings: What To Expect

2026-08-09 02:39:46

Surgery Partners (SGRY) is set to announce its Q2 earnings before market hours on Monday. The company beat revenue and EPS expectations last quarter, but analysts expect flat year-on-year revenue growth for the upcoming quarter. Despite some positive sentiment in the outpatient & specialty care segment, Surgery Partners' share price has been down, and the company has missed Wall Street's revenue estimates multiple times in the past two years.

Surgery Partners, Inc. (SGRY) stock price, news, quote and history

2026-08-08 08:39:46

This Yahoo Finance page provides comprehensive financial information for Surgery Partners, Inc. (SGRY), including its current stock price, recent news, historical data, and analyst insights. It details the company's business overview, performance against benchmarks like the S&P 500, and key financial metrics. The page also features an upcoming Q2 2026 earnings call and comparison tools for similar companies.

...
SURGERY PARTNERS Q2 2026 Earnings Preview: Recent $SGRY Insider Trading, Hedge Fund Activity, and More

2026-08-07 21:10:54

SURGERY PARTNERS ($SGRY) is set to release its Q2 2026 earnings on August 10th, with analysts expecting $846.97 million in revenue and $0.06 EPS. Recent insider trading shows 12 sales and no purchases in the last six months, totaling over $1.2 million in sales by executives. Hedge fund activity indicates mixed sentiment, with 102 institutional investors increasing positions and 74 decreasing, while analysts have a median price target of $20.0 for SGRY.

...
Surgery Partners Inc (SGRY) Earnings Forecast: Future EPS & Revenue Growth Estimates

2026-08-07 20:10:54

This article provides an earnings forecast for Surgery Partners Inc (SGRY), highlighting its current earnings forecast score, analyst ratings, and price targets. It details expected revenue and EPS for upcoming quarters and compares SGRY's ratings to its peers in the Healthcare Providers & Services industry.

...
Does Surgery Partners' (SGRY) Reaffirmed 2026 Outlook Clarify Its Execution Strength or Strategic Limits?

2026-08-06 20:10:54

Surgery Partners, Inc. (SGRY) has reaffirmed its 2026 revenue outlook of US$3.35 billion to US$3.45 billion, signaling management's confidence in operational execution. While this provides near-term clarity, it does not alleviate concerns regarding the company's leverage, rising interest costs on US$2.2 billion of debt, and the need for profitability. Investors are encouraged to consider both the company's positive outlook and more cautious analyst views.

...
Surgery Partners, Inc. (NASDAQ:SGRY) Given Consensus Rating of "Moderate Buy" by Brokerages

2026-08-06 20:10:54

Surgery Partners, Inc. (NASDAQ:SGRY) has received a consensus "Moderate Buy" rating from brokerages, with an average 12-month price target of $21.60. The company recently exceeded earnings expectations, reporting a smaller-than-expected loss and higher revenue. Institutional ownership has also shown a recent increase, indicating growing investor confidence.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi